Related Experiment Video
Updated: Jan 18, 2026

08:50
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
1.3K
Machine learning for extracellular vesicles enables diagnostic and therapeutic nanobiotechnology
Ashutosh Tiwari1, Widodo2, Dyah Ika Krisnawati3,4
1International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, 11031, Taiwan.
Journal of Nanobiotechnology
|January 16, 2026
Summary
Machine learning (ML) accelerates extracellular vesicle (EV) research by analyzing complex data for therapeutic advancements. This review maps ML applications in EV biology, from imaging to drug delivery, guiding AI integration for precision medicine.
Area of Science:
- Nanomedicine
- Biotechnology
- Computational Biology
Background:
- Extracellular vesicles (EVs) are bioactive nanomaterials with therapeutic potential.
- Machine learning (ML) is revolutionizing biomedical data analysis, including EV research.
- EV complexity and heterogeneity present significant analytical challenges.
Purpose of the Study:
- To synthesize ML-enabled studies in EV research.
- To provide a structured map linking EV data modalities, ML algorithms, and clinical applications.
- To discuss technical barriers and frontier developments in AI-integrated EV platforms.
Main Methods:
- Organized review of ML applications in EV research based on data modality (imaging, omics, cytometry).
- Categorization by ML algorithmic paradigms (CNNs, random forests, autoencoders, GNNs).
- Analysis of translational applications (diagnosis, prognosis, drug delivery, manufacturing QC).
Main Results:
- ML has driven advances in automated imaging, multi-omics integration, disease classification, and therapeutic engineering for EVs.
- A unified taxonomy links EV data, ML architectures, and clinical use-cases.
- Key challenges include data sparsity, batch variability, and model explainability.
Conclusions:
- ML-enhanced EV platforms are progressing towards clinically actionable systems.
- AI integration is crucial for advancing EV technologies in precision medicine, particularly in oncology.
- Future directions include federated learning, self-supervised models, and real-time EV analytics.

